-
1
المؤلفون: JR Barrett, SE Silk, CG Mkindi, KM Kwiatkowska, MM Hou, AM Lias, WF Kalinga, IM Mtaka, K McHugh, M Bardelli, H Davies, LDW King, NJ Edwards, VS Chauhan, P Mukherji, S Rwezaula, CE Chitnis, AI Olotu, AM Minassian, SJ Draper, CM Nielsen
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::107f1e6152327a535d28955d719dbbf8
https://doi.org/10.1101/2023.03.17.23287040 -
2دورية أكاديمية
المؤلفون: Silk SE; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Kalinga WF; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Salkeld J; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Mtaka IM; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Ahmed S; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Milando F; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Diouf A; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Bundi CK; Kenya Medical Research Institute (KEMRI) Centre for Geographic Medicine, KEMRI-Wellcome Trust Research Programme and Accredited Research Centre, Open University, Kilifi, Kenya., Balige N; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Hassan O; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Mkindi CG; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Rwezaula S; Muhimbili National Hospital, Dar es Salaam, Tanzania., Athumani T; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Mswata S; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Lilolime NS; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Simon B; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Msami H; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Mohamed M; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., David DM; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Mohammed L; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Nyaulingo G; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Mwalimu B; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Juma O; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Mwamlima TG; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Sasamalo IA; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Mkumbange RP; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Kamage JJ; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Barrett JR; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., King LDW; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Hou MM; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Pulido D; Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Oxford, UK., Carnrot C; Novavax AB, Uppsala, Sweden., Lawrie AM; Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Oxford, UK., Cowan RE; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Nugent FL; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Roberts R; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Cho JS; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Long CA; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Nielsen CM; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Miura K; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Draper SJ; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Olotu AI; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Minassian AM; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK. Electronic address: angela.minassian@bioch.ox.ac.uk.
المصدر: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Jun 13. Date of Electronic Publication: 2024 Jun 13.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE
-
3دورية أكاديمية
المؤلفون: Barrett JR; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; Jenner Institute, University of Oxford, Oxford, United Kingdom., Silk SE; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; Jenner Institute, University of Oxford, Oxford, United Kingdom., Mkindi CG; Ifakara Health Institute, Bagamoyo, Tanzania., Kwiatkowska KM; Department of Biochemistry, University of Oxford, Oxford, United Kingdom., Hou MM; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; Jenner Institute, University of Oxford, Oxford, United Kingdom., Lias AM; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; Jenner Institute, University of Oxford, Oxford, United Kingdom., Kalinga WF; Ifakara Health Institute, Bagamoyo, Tanzania., Mtaka IM; Ifakara Health Institute, Bagamoyo, Tanzania., McHugh K; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; Jenner Institute, University of Oxford, Oxford, United Kingdom., Bardelli M; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; Jenner Institute, University of Oxford, Oxford, United Kingdom., Davies H; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; Jenner Institute, University of Oxford, Oxford, United Kingdom., King LDW; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; Jenner Institute, University of Oxford, Oxford, United Kingdom., Edwards NJ; Jenner Institute, University of Oxford, Oxford, United Kingdom., Chauhan VS; International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India., Mukherjee P; Multi Vaccines Development Program (MVDP), New Delhi, India., Rwezaula S; Muhimbili National Hospital, Dar es Salaam, Tanzania., Chitnis CE; Unité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, Paris, France., Olotu AI; Ifakara Health Institute, Bagamoyo, Tanzania., Minassian AM; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; Jenner Institute, University of Oxford, Oxford, United Kingdom., Draper SJ; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; Jenner Institute, University of Oxford, Oxford, United Kingdom., Nielsen CM; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; Jenner Institute, University of Oxford, Oxford, United Kingdom.
المصدر: Frontiers in immunology [Front Immunol] 2024 Jan 17; Vol. 14, pp. 1193079. Date of Electronic Publication: 2024 Jan 17 (Print Publication: 2023).
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
مواضيع طبية MeSH: Vaccines* , Malaria, Vivax*/prevention & control, Humans ; Plasmodium falciparum ; Bone Marrow ; Antigens, Protozoan ; Adjuvants, Immunologic ; Immunoglobulin G
-
4دورية أكاديمية
المؤلفون: Banga R; Services of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland., Procopio FA; Services of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland., Lana E; Services of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland., Gladkov GT; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Roseto I; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Parsons EM; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; Infectious Disease Division, Brigham and Women's Hospital, Boston, MA, USA., Lian X; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; Infectious Disease Division, Brigham and Women's Hospital, Boston, MA, USA., Armani-Tourret M; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Bellefroid M; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Gao C; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Kauzlaric A; Translational Bioinformatics and Statistics Department of Oncology, University of Lausanne Swiss Cancer Center, Lausanne, Switzerland., Foglierini M; Services of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland., Alfageme-Abello O; Services of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland., Sluka SHM; Newborn Screening Switzerland, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland., Munoz O; Services of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland., Mastrangelo A; Services of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland., Fenwick C; Services of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland., Muller Y; Services of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland., Mkindi CG; Ifakara Health Institute, Bagamoyo, United Republic of Tanzania; Department of Medical Parasitology and Infection Biology, Clinical Immunology Unit, Swiss Tropical and Public Health Institute, Basel, Switzerland., Daubenberger C; Department of Medical Parasitology and Infection Biology, Clinical Immunology Unit, Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, 4001 Basel, Switzerland., Cavassini M; Services of Infectious Diseases, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland., Trunfio R; Services of Vascular Surgery, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland., Déglise S; Services of Vascular Surgery, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland., Corpataux JM; Services of Vascular Surgery, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland., Delorenzi M; Translational Bioinformatics and Statistics Department of Oncology, University of Lausanne Swiss Cancer Center, Lausanne, Switzerland., Lichterfeld M; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; Infectious Disease Division, Brigham and Women's Hospital, Boston, MA, USA., Pantaleo G; Services of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland; Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland., Perreau M; Services of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland. Electronic address: matthieu.perreau@chuv.ch.
المصدر: Cell host & microbe [Cell Host Microbe] 2023 Oct 11; Vol. 31 (10), pp. 1714-1731.e9. Date of Electronic Publication: 2023 Sep 25.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101302316 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1934-6069 (Electronic) Linking ISSN: 19313128 NLM ISO Abbreviation: Cell Host Microbe Subsets: MEDLINE
مواضيع طبية MeSH: HIV Infections* , Simian Acquired Immunodeficiency Syndrome* , Simian Immunodeficiency Virus*, Animals ; Humans ; CD4-Positive T-Lymphocytes ; Anti-Retroviral Agents/therapeutic use ; Lymph Nodes ; Dendritic Cells
-
5دورية أكاديمية
المؤلفون: Kwiatkowska KM; Department of Biochemistry, University of Oxford, Oxford, United Kingdom., Mkindi CG; Department of Intervention and Clinical Trials, Ifakara Health Institute, Bagamoyo, Tanzania., Nielsen CM; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.
المصدر: Frontiers in immunology [Front Immunol] 2022 Nov 17; Vol. 13, pp. 1045529. Date of Electronic Publication: 2022 Nov 17 (Print Publication: 2022).
نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
مواضيع طبية MeSH: Vaccinology* , COVID-19*/prevention & control, Animals ; Humans ; COVID-19 Vaccines ; SARS-CoV-2 ; Lymphoid Tissue
-
6دورية أكاديمية
المؤلفون: Mwamlima TG; Ifakara Health Institute, Bagamoyo, Tanzania.; Department of Life Science and Bio-Engineering, The Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania., Mwakasungula SM; Ifakara Health Institute, Bagamoyo, Tanzania., Mkindi CG; Ifakara Health Institute, Bagamoyo, Tanzania., Tambwe MM; Ifakara Health Institute, Bagamoyo, Tanzania., Mswata SS; Ifakara Health Institute, Bagamoyo, Tanzania., Mbwambo SG; Ifakara Health Institute, Bagamoyo, Tanzania., Mboya MF; Amref Health Africa-Tanzania, Dar es Salaam, Tanzania., Draper SJ; Department of Biochemistry, University of Oxford, Oxford OX1 3QU, United Kingdom., Silk SE; Amref Health Africa-Tanzania, Dar es Salaam, Tanzania., Mpina MG; Ifakara Health Institute, Bagamoyo, Tanzania., Vianney JM; Department of Life Science and Bio-Engineering, The Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania., Olotu AI; Ifakara Health Institute, Bagamoyo, Tanzania.
المصدر: The Pan African medical journal [Pan Afr Med J] 2022 Oct 07; Vol. 43, pp. 60. Date of Electronic Publication: 2022 Oct 07 (Print Publication: 2022).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: African Field Epidemiology Network Country of Publication: Uganda NLM ID: 101517926 Publication Model: eCollection Cited Medium: Internet ISSN: 1937-8688 (Electronic) NLM ISO Abbreviation: Pan Afr Med J Subsets: MEDLINE
مواضيع طبية MeSH: Malaria, Falciparum*/epidemiology , Malaria Vaccines* , Malaria*/epidemiology, Infant ; Humans ; Tanzania/epidemiology ; Cross-Sectional Studies ; Immunoglobulin G ; Antibodies, Protozoan ; Plasmodium falciparum
-
7دورية أكاديمية
المؤلفون: Mkindi CG; Department of Medical Parasitology and Infection Biology, Clinical Immunology, Swiss Tropical and Public Health Institute, Socinstr. 57, 4002, Basel, Switzerland.; University of Basel, Basel, Switzerland.; Ifakara Health Institute, Bagamoyo, Tanzania., Marandu EA; St Francis Referral Hospital, Ifakara, Tanzania., Masawa N; Ifakara Health Institute, Bagamoyo, Tanzania., Bani F; Ifakara Health Institute, Bagamoyo, Tanzania., Nyuri A; Ifakara Health Institute, Bagamoyo, Tanzania., Byakuzana T; Ifakara Health Institute, Bagamoyo, Tanzania., Klimkait T; University of Basel, Basel, Switzerland., Ding S; EuroVacc Foundation, Amsterdam, The Netherlands., Pantaleo G; Service of Immunology and Allergy, Lausanne University Hospital, Lausanne, Switzerland.; Swiss Vaccine Research Institute, Lausanne, Switzerland., Battegay M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland., Orlova-Fink N; Department of Medical Parasitology and Infection Biology, Clinical Immunology, Swiss Tropical and Public Health Institute, Socinstr. 57, 4002, Basel, Switzerland.; Ifakara Health Institute, Bagamoyo, Tanzania., Weisser-Rohacek M; Department of Medical Parasitology and Infection Biology, Clinical Immunology, Swiss Tropical and Public Health Institute, Socinstr. 57, 4002, Basel, Switzerland.; Ifakara Health Institute, Bagamoyo, Tanzania.; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland., Daubenberger C; Department of Medical Parasitology and Infection Biology, Clinical Immunology, Swiss Tropical and Public Health Institute, Socinstr. 57, 4002, Basel, Switzerland. claudia.daubenberger@swisstph.ch.; Ifakara Health Institute, Bagamoyo, Tanzania. claudia.daubenberger@swisstph.ch.
المصدر: BMC research notes [BMC Res Notes] 2019 Sep 06; Vol. 12 (1), pp. 561. Date of Electronic Publication: 2019 Sep 06.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Biomed Central Country of Publication: England NLM ID: 101462768 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-0500 (Electronic) Linking ISSN: 17560500 NLM ISO Abbreviation: BMC Res Notes Subsets: MEDLINE
مواضيع طبية MeSH: CD4 Lymphocyte Count*, Anti-Retroviral Agents/*therapeutic use , HIV Infections/*drug therapy , HIV-1/*drug effects , Lymph Node Excision/*methods, Adult ; Chronic Disease ; Female ; HIV Infections/virology ; HIV-1/physiology ; Humans ; Lymph Nodes/pathology ; Lymph Nodes/virology ; Male ; Middle Aged ; Reproducibility of Results ; Rural Population/statistics & numerical data ; Tanzania ; Volunteers ; Young Adult